# Acceptance Cycle 1 — Post-Promotion Evidence & Risk Gate Validation

**Program:** Post-Promotion Controlled Beta Acceptance Program
**Governance baseline:** EVIDENCE_RISK_GATE (promoted commit `dcf72aeb29b9c5a3f633b28a67dec842ff972f30`)
**Hermes version:** 1.3.0
**Baseline commit (HEAD at run):** `82229d83f45dcd2477a4a4c267dd200af4da77c7`
**Run timestamp:** 2026-08-13 (UTC)
**Autonomous execution:** DISABLED · **Repository mutation:** DISABLED

> New acceptance-cycle artifact. Does not overwrite Cycle 7 / Cycle 8 / promotion
> artifacts. Immutable historical evidence (Trial 001, Cycle 7 frozen dataset,
> historical journal events, legacy APPROVED values) was not modified.

## Cohort (read-only, provenance established)

| Repo | Commit SHA | Branch | Baseline match |
|------|-----------|--------|----------------|
| cognikid-web | `4e9dfbde238602820f979729da88f073488cc584` | main | yes (controlled_beta_001.json) |
| faithtech-blueprint | `c5a792b1d6919f0c02f976ff435ec0f2859ccc06` | main | yes |
| inspirevoice-backend | `83f1c00959c728fb9ee59648c2af85d459c4c6b4` | main | yes |

3 repositories (within the 2–3 limit). Each scanned read-only via
`analyze_engineering(ri)` on its existing `REPOSITORY_INTELLIGENCE.json`.
No checkout / reset / clean / mutation performed on any target repository.

## Scan summary (M2)

- Total findings: **877** (faithtech-blueprint 766, inspirevoice-backend 103, cognikid-web 8)
- Gate-state distribution (machine, gate mode): `INSUFFICIENT_EVIDENCE` 694, `DUPLICATE` 183
- **Machine ACTIONABLE emitted: 0 · Machine NOT_ACTIONABLE emitted: 0** (label firewall intact)
- Evidence enrichment: v1 applied (deterministic, label-free); v2 not used (no v2_context)
- Target repository mutations: **0**

## Human review queue (M3)

- 877-item evidence-ranked blind queue, 100% evidence coverage
- Ranked by evidence/risk review-ranking (NOT actionability)
- Every item traceable; no hidden machine actionability; no mission generated yet
- Blind fields only (title, severity, category, affected path, evidence, enrichment, uncertainty)

## Adjudication (M4) — Batch 1 (items #1–#25)

Persisted via canonical Human Review path (`create_adjudication`), operator
`operator:acceptance-review`, append-only. NEEDS_MORE_EVIDENCE items carry the
specific missing-evidence rationale in `notes` so future evidence collection can
resolve them.

| Classification | Count | Rate |
|----------------|-------|------|
| ACTIONABLE | 1 | 4% |
| NOT_ACTIONABLE | 9 | 36% |
| NEEDS_MORE_EVIDENCE | 15 | 60% |
| FALSE_POSITIVE | 0 | 0% |
| DUPLICATE | 0 | 0% |
| UNKNOWN | 0 | 0% |

Only **#1** (FINDING-001, faithtech-blueprint — hardcoded credential in a
production auth endpoint) was adjudicated ACTIONABLE.

## Authority boundary (M5)

- Human ACTIONABLE count in system of record: **1** (FINDING-001 only)
- Every non-ACTIONABLE finding → **0 missions** (no leakage): VERIFIED
- Machine gate state alone never authorizes a mission: VERIFIED
- UNREVIEWED / LEGACY_APPROVED / NME / NOT_ACTIONABLE / FALSE_POSITIVE /
  DUPLICATE / UNKNOWN / POLICY_SUPPRESSED → NO MISSION: VERIFIED
- ACTIONABLE → MISSION ELIGIBLE: VERIFIED (only FINDING-001)

## Mission prioritization (M6) + recommendation (M7)

- FINDING-001 passed to MissionPrioritizer: **selected = 1, deferred = 0**,
  selection_status = SELECTED, priority_score = 2.5
- Mission recommendation: **1 DRAFT mission**, `state = DRAFT` (not executed)
- `originating_finding_id = FINDING-001`
- `governance_approval_reference = HUMAN-ADJUDICATION-FINDING-001`
- `traceability = True`
- Non-ACTIONABLE leakage = 0 · NME leakage = 0 · suppression leakage = 0 ·
  legacy-only leakage = 0

## Operator burden + quality (M8)

- Findings reviewed (batch 1): 25 / 25 (100% completion for batch)
- Mission eligibility rate: 4% · ACTIONABLE retention: 1
- Evidence sufficiency rate (decided w/ sufficient evidence): 40%
- Median review time / total review burden: **NOT_OBSERVED** (not captured; not fabricated)
- Cohort total findings: 877 (852 remain pending future review cycles)

## Auditability + reproducibility (M9)

- Journal integrity: **PASS** (canonical payload_sha256 verification; §11C proved
  adjudication/suppression journal events verifiable)
- Unique event IDs: True · Historical mutation count: 0
- Target repository mutations: **0**
- Database reopen: successful (append-only new adjudications)

## Canonical verification (M10)

- Backend canonical suite: **1434 passed, 0 failed, exit 0, 262.82s**
- Matches promotion-baseline repeat (1434/1434 ×2) → no regression
- Frontend / packaging: NOT_REQUIRED (no source change during this program)

## Defects found / resolved this cycle

- None. The promoted gate behaved correctly under all authority-boundary checks.
  (Prior promotion defects D1–D10 were resolved before promotion; see
  EVIDENCE_RISK_GATE_PROMOTION_READINESS_REPORT.md.)

## Acceptance decision (M11)

**CONTROLLED_BETA_ACCEPTED_WITH_LIMITATIONS**

All minimum acceptance conditions satisfied:
- `unsafe_automation_rate = 0.0` ✓
- `mission_traceability = 100%` ✓
- machine actionability authority = 0 ✓
- non-ACTIONABLE mission leakage = 0 ✓
- target repository mutations = 0 ✓
- mission executions = 0 ✓
- journal integrity = PASS ✓
- canonical backend gate = PASS (1434/1434) ✓
- no unresolved severity-high promotion defect ✓

**Limitations (not blockers):**
1. Only Batch 1 (25 of 877 queue items) adjudicated; 852 findings remain for
   future review cycles.
2. Source `REPOSITORY_INTELLIGENCE.json` artifacts contained findings but no
   `recommendation_assessments`, so mission generation was only demonstrable for
   the single ACTIONABLE finding (canonical pattern; recommendation candidate
   synthesized from finding attributes and clearly labeled).
3. Operator review-time / total-burden metrics NOT_OBSERVED (not captured).

The Evidence & Risk Gate operated correctly as the Controlled Beta governance
baseline: machine observed and routed, human ACTIONABLE adjudication was the
sole authority that made a finding mission-eligible, legacy/non-actionable/
unreviewed states were correctly prevented from authorizing missions, and
unsafe automation remained exactly zero.

## Next recommendation (M13 → forward)

Continue Controlled Beta with additional review batches (852 remaining findings)
and broader cohort as operator availability permits. Do NOT enable autonomous
mission execution or repository mutation.
